These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28694009)

  • 1. Role of dual red imaging to guide intravariceal sclerotherapy injection of esophageal varices (with videos).
    Furuichi Y; Gotoda T; Kasai Y; Takeuchi H; Yoshimasu Y; Kawai T; Itoi T
    Gastrointest Endosc; 2018 Feb; 87(2):360-369. PubMed ID: 28694009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secure intravariceal sclerotherapy with red dichromatic imaging decreases the recurrence rate of esophageal varices: A propensity score matching analysis.
    Furuichi Y; Abe M; Kasai Y; Takeuchi H; Yoshimasu Y; Itoi T
    J Hepatobiliary Pancreat Sci; 2021 May; 28(5):431-442. PubMed ID: 33453078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual red imaging (novel advanced endoscopy) can increase visibility and can predict the depth in diagnosing esophageal varices.
    Furuichi Y; Gotoda T; Moriyasu F; Ogawa S; Kasai Y; Takeuchi H; Yoshimasu Y; Sano T; Sugimoto K; Kawai T; Kobayashi Y; Nakamura I; Itoi T
    J Gastroenterol; 2017 May; 52(5):568-576. PubMed ID: 27502189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red dichromatic imaging reduces endoscopic treatment time of esophageal varices by increasing bleeding point visibility (with video).
    Furuichi Y; Abe M; Takeuchi H; Yoshimasu Y; Itoi T
    Dig Endosc; 2022 Jan; 34(1):87-95. PubMed ID: 33971049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and recurrence factors after endoscopic injection sclerotherapy for esophageal varices: Multivariate analysis with the propensity score matching: Multivariate analysis with propensity score matching.
    Abe M; Furuichi Y; Takeuchi H; Yoshimasu Y; Itoi T
    Dig Endosc; 2022 Jan; 34(2):367-378. PubMed ID: 34411350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial.
    Shigemitsu T; Yoshida T; Harada T; Takeo Y; Nakamura H; Okita K
    Hepatogastroenterology; 2000; 47(33):733-7. PubMed ID: 10919021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete eradication by endoscopic injection sclerotherapy reduces the recurrence of esophageal varices].
    Matsumoto H; Matsumoto M; Nemoto M; Suzuki F; Souda K; Kitahara H; Kobayashi Y; Tsugiki M; Kawasaki T; Kanai K
    Nihon Shokakibyo Gakkai Zasshi; 1994 Oct; 91(10):1921-8. PubMed ID: 7967127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.
    Iso Y; Kawanaka H; Tomikawa M; Matsumata T; Kitano S; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):467-71. PubMed ID: 9164520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic injection sclerotherapy using a transparent overtube with intraluminal negative pressure (np-EIS) for esophageal varices.
    Kawano T; Nakamura H; Inoue H; Endo M
    Surg Endosc; 1990; 4(1):15-7. PubMed ID: 2315820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial.
    Watanabe K; Hikichi T; Takagi T; Suzuki R; Nakamura J; Sugimoto M; Kikuchi H; Konno N; Takasumi M; Sato Y; Hashimoto M; Irie H; Obara K; Ohira H
    Fukushima J Med Sci; 2018 Dec; 64(3):133-141. PubMed ID: 30344206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: Single-center case-control study.
    Deguchi H; Kato J; Maeda Y; Moribata K; Shingaki N; Niwa T; Inoue I; Maekita T; Iguchi M; Tamai H; Ichinose M
    Dig Endosc; 2016 Jan; 28(1):42-9. PubMed ID: 26295791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure.
    Kong DR; Wang JG; Chen C; Yu FF; Wu Q; Xu JM
    World J Gastroenterol; 2015 Mar; 21(9):2800-6. PubMed ID: 25759552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of characteristics of recurrent esophageal varices after endoscopic ligation versus endoscopic ligation plus sclerotherapy.
    Yoshida H; Tajiri T; Mamada Y; Taniai N; Hirakata A; Kawano Y; Mizuguchi Y; Shimizu T; Takahashi T
    Hepatogastroenterology; 2004; 51(56):457-61. PubMed ID: 15086182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation: Effect of portal hemodynamics and longitudinal clinical course.
    Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O; Kawahira H; Yamaguchi T
    Dig Endosc; 2016 Mar; 28(2):152-61. PubMed ID: 26505617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic recurrence of esophageal varices is associated with the specific EUS abnormalities: severe periesophageal collateral veins and large perforating veins.
    Irisawa A; Saito A; Obara K; Shibukawa G; Takagi T; Shishido H; Sakamoto H; Sato Y; Kasukawa R
    Gastrointest Endosc; 2001 Jan; 53(1):77-84. PubMed ID: 11154493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of esophageal varices: a randomized controlled trial comparing endoscopic sclerotherapy and EUS-guided sclerotherapy of esophageal collateral veins.
    de Paulo GA; Ardengh JC; Nakao FS; Ferrari AP
    Gastrointest Endosc; 2006 Mar; 63(3):396-402; quiz 463. PubMed ID: 16500386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of endosonography in sclerotherapy of esophageal varices.
    Ziegler K; Gregor M; Zeitz M; Zimmer T; Habermann F; Riecken EO
    Endoscopy; 1991 Sep; 23(5):247-50. PubMed ID: 1743122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study.
    Akahoshi T; Tomikawa M; Tsutsumi N; Hashizume M; Maehara Y
    Dig Endosc; 2014 Mar; 26(2):172-7. PubMed ID: 23650913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicenter randomized trial comparing banding ligation with sclerotherapy of esophageal varices.
    Masci E; Stigliano R; Mariani A; Bertoni G; Baroncini D; Cennamo V; Micheletti G; Casetti T; Tansini P; Buscarini E; Ranzato R; Norberto L
    Hepatogastroenterology; 1999; 46(27):1769-73. PubMed ID: 10430341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of patients with esophageal varices after endoscopic injection sclerotherapy using multiplanar reconstruction MDCT images.
    Kodama H; Aikata H; Takaki S; Takahashi S; Toyota N; Ito K; Chayama K
    AJR Am J Roentgenol; 2009 Jan; 192(1):122-30. PubMed ID: 19098190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.